학술논문
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial
Document Type
Article
Author
Patil, Vijay; Noronha, Vanita; Dhumal, Sachin Babanrao; Joshi, Amit; Menon, Nandini; Bhattacharjee, Atanu; Kulkarni, Suyash; Ankathi, Suman Kumar; Mahajan, Abhishek; Sable, Nilesh; Nawale, Kavita; Bhelekar, Arti; Mukadam, Sadaf; Chandrasekharan, Arun; Das, Sudeep; Vallathol, Dilip; D'Souza, Hollis; Kumar, Amit; Agrawal, Amit; Khaddar, Satvik; Rathnasamy, Narmadha; Shenoy, Ramnath; Kashyap, Lakhan; Rai, Rahul Kumar; Abraham, George; Saha, Saswata; Majumdar, Swaratika; Karuvandan, Naveen; Simha, Vijai; Babu, Vasu; Elamarthi, Prahalad; Rajpurohit, Annu; Kumar, Kanteti Aditya Pavan; Srikanth, Anne; Ravind, Rahul; Banavali, Shripad; Prabhash, Kumar
Source
In The Lancet Global Health September 2020 8(9):e1213-e1222
Subject
Language
ISSN
2214-109X